MyFinsight
Home
Blog
About
Contact
Download
Download image
Biopharmaceutical And Other
Biopharmaceutical Revenue
$6,536K
Biopharmaceutical And Other
Contract Manufacturing...
$3,128K
Testing
$493,154K
Product
$14,327K
Biopharmaceutical And Other
$9,664K
Total revenue
$517,145K
(19.54%↑ Y/Y)
Gross profit
$362,532K
(21.60%↑ Y/Y)
Total cost of revenue
$154,613K
(4.74%↑ Y/Y)
Income (loss) from
operations
$57,777K
(257.93%↑ Y/Y)
Other income, net
$10,424K
(8.56%↑ Y/Y)
Total operating
expenses
$304,755K
(8.07%↑ Y/Y)
Cost of
revenue-Testing
$127,562K
Intangible asset
amortization - cost of revenue
$10,666K
(-7.67%↓ Y/Y)
Cost of
revenue-Product
$8,807K
Cost of
revenue-Biopharmaceutical And Other
$7,578K
Income (loss) before
income taxes
$68,201K
(164.92%↑ Y/Y)
General and
administrative
$110,784K
(0.16%↑ Y/Y)
Selling and marketing
$100,165K
(4.96%↑ Y/Y)
Research and development
$70,814K
(2.19%↑ Y/Y)
Impairment of assets
$20,505K
(508.82%↑ Y/Y)
Intangible asset
amortization - operating...
$2,487K
Net income (loss)
$66,353K
(174.89%↑ Y/Y)
Income tax provision
(benefit)
$1,848K
(15.07%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
VERACYTE, INC. (VCYT)
VERACYTE, INC. (VCYT)